SignatureFD’s Verrica Pharmaceuticals VRCA Stock Holding History

SignatureFD’s Portfolio VRCA Stock Details VRCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-7	Closed	-$1K	–	3227
2021 Q2	$1K	Buy	+7	New	+$848	﹤0.01%	2857

Other funds holding VRCA

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

KCM

Kornitzer Capital Management Shawnee Mission, Kansas $4.79B AUM 30.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return

ACM

Altium Capital Management New York $47.5M AUM 115.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

SignatureFD's VRCA Position: Q3 2021 in Review

SignatureFD sold out of Verrica Pharmaceuticals (VRCA) in Q3 2021, closing a stake of 7 shares — an estimated $1K sold.

SignatureFD first reported a position in VRCA in Q2 2021 and held it in 1 quarter. The position peaked at $1K in Q2 2021. 49 funds tracked by Wall St. Rank hold VRCA as of Q3 2021.

SignatureFD reported no remaining Verrica Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
SignatureFD sold 7 Verrica Pharmaceuticals shares in Q3 2021, an estimated $1K.
SignatureFD first reported a position in Verrica Pharmaceuticals in Q2 2021 and held it in 1 quarter.
SignatureFD's Verrica Pharmaceuticals position peaked at $1K in Q2 2021.
49 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q3 2021.

Based on SignatureFD's 13F filing for Q3 2021, filed 28 Oct 2021.